Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Pussell

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Complement and Inflammation|January 1, 1991
Activation of rabbit C3: studies of the generation of cleavage products in vitro and of their metabolism in vivoP W Peake, J A Charlesworth, B A Pussell
British Medical Journal|July 28, 1979
Inhibition of reticuloendothelial function by gold and its relation to postinjection reactionsB D Williams, C M Lockwood, B A Pussell
The Medical Journal of Australia|January 12, 1974
The subcutaneous use of heparin in the prevention of venous thrombosis after myocardial infarctionW R Pitney, B A Pussell, M Harris, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1997
Nitric oxide synthase inhibition in a spontaneously hypertensive rat model of diabetic nephropathyJ Wessels, P Peake, B A Pussell, et al.
Kidney International|November 26, 1999
C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptorP W Peake, S O'Grady, B A Pussell, et al.
Lancet (London, England)|June 23, 1979
Defective reticuloendothelial system function in rheumatoid arthritisB D Williams, B A Pussell, C M Lockwood, et al.
Journal of Clinical & Laboratory Immunology|February 1, 1990
Studies of the acute phase response in experimental serum sicknessP Martyn, J A Charlesworth, P W Peake, et al.
Clinical and Experimental Immunology|July 1, 1995
Complement inhibition by human vitronectin involves non-heparin binding domainsM Sheehan, C A Morris, B A Pussell, et al.
European Journal of Clinical Investigation|December 13, 1997
Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytesP W Peake, S O'Grady, B A Pussell, et al.
Clinical and Experimental Immunology|November 1, 1996
The behaviour of human vitronectin in vivo: effects of complement activation, conformation and phosphorylationP W Peake, J D Greenstein, B A Pussell, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Complement and Inflammation|January 1, 1991
Activation of rabbit C3: studies of the generation of cleavage products in vitro and of their metabolism in vivoP W Peake, J A Charlesworth, B A Pussell
British Medical Journal|July 28, 1979
Inhibition of reticuloendothelial function by gold and its relation to postinjection reactionsB D Williams, C M Lockwood, B A Pussell
The Medical Journal of Australia|January 12, 1974
The subcutaneous use of heparin in the prevention of venous thrombosis after myocardial infarctionW R Pitney, B A Pussell, M Harris, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1997
Nitric oxide synthase inhibition in a spontaneously hypertensive rat model of diabetic nephropathyJ Wessels, P Peake, B A Pussell, et al.
Kidney International|November 26, 1999
C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptorP W Peake, S O'Grady, B A Pussell, et al.
Lancet (London, England)|June 23, 1979
Defective reticuloendothelial system function in rheumatoid arthritisB D Williams, B A Pussell, C M Lockwood, et al.
Journal of Clinical & Laboratory Immunology|February 1, 1990
Studies of the acute phase response in experimental serum sicknessP Martyn, J A Charlesworth, P W Peake, et al.
Clinical and Experimental Immunology|July 1, 1995
Complement inhibition by human vitronectin involves non-heparin binding domainsM Sheehan, C A Morris, B A Pussell, et al.
European Journal of Clinical Investigation|December 13, 1997
Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytesP W Peake, S O'Grady, B A Pussell, et al.
Clinical and Experimental Immunology|November 1, 1996
The behaviour of human vitronectin in vivo: effects of complement activation, conformation and phosphorylationP W Peake, J D Greenstein, B A Pussell, et al.
Pageof 6